We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,307
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WIL
8501
DELISTED
iPath Women in Leadership ETN
WIL
-259
Closed -$18K
NH
8502
DELISTED
NantHealth, Inc
NH
-357
Closed -$4K
CCXI
8503
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
-7,000
Closed -$47K
RMO
8504
DELISTED
Romeo Power, Inc.
RMO
$0 ﹤0.01%
+10
New +$99
IEA
8505
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
-1,840
Closed -$9K
IEAWW
8506
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$0 ﹤0.01%
+5,749
New +$255
CTXS
8507
CALL
DELISTED
Citrix Systems Inc
CTXS
-370,195
Closed -$35.7M
ZEAL
8508
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
-756
Closed -$19K
ALJJ
8509
DELISTED
ALJ Regional Holdings Inc
ALJJ
-4,793
Closed -$7K
VANIW
8510
DELISTED
Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
$0 ﹤0.01%
133
-192
-59% -$294
ALNA
8511
DELISTED
Allena Pharmaceuticals
ALNA
-3,258
Closed -$13K
JDIV
8512
DELISTED
JPMorgan U.S. Dividend ETF
JDIV
-152
Closed -$4K
MENV
8513
DELISTED
AdvisorShares North Square McKee ESG Core Bond ETF
MENV
-852
Closed -$22K
CDK
8514
CALL
DELISTED
CDK Global, Inc.
CDK
-11,900
Closed -$572K
COHR
8515
PUT
DELISTED
Coherent Inc
COHR
-30,000
Closed -$4.61M
IMRNW
8516
DELISTED
Immuron Limited Warrants
IMRNW
$0 ﹤0.01%
+100
New +$81
CERN
8517
PUT
DELISTED
Cerner Corp
CERN
-313,300
Closed -$21.4M
CTK
8518
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
-93
Closed -$6K
NDRAW
8519
DELISTED
ENDRA Life Sciences Inc. Warrants
NDRAW
$0 ﹤0.01%
178
-7,100
-98% -$2.58K
DMRE
8520
DELISTED
DeltaShares S&P EM 100 & Managed Risk ETF
DMRE
-119
Closed -$6K
GSKY
8521
CALL
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
-131,000
Closed -$897K
NSPRZ
8522
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$0 ﹤0.01%
101,100
LSLT
8523
DELISTED
Pacer Salt Low truBeta US Market ETF
LSLT
-1,529
Closed -$43K
SLT
8524
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
-100
Closed -$3K
VCRA
8525
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$0 ﹤0.01%
5
-337
-99% -$7.39K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.